新冠疫情期间丹麦非新冠疾病住院与死亡率:全国人群队列研究
该全国人群队列研究纳入丹麦全部1岁以上居民5,753,179人,观察567.8百万人周,比较新冠疫情期间(2020年3月11日至2021年1月27日)与疫情前基线(2019年3月13日至2020年3月10日)非新冠疾病住院与30天死亡率。首次全国封锁后非新冠住院率从基线204.1/10万人周降至142.8/10万人周(率比0.70,95%CI 0.66–0.74),第二次封锁时降至158.3/10万人周(0.78,0.73–0.82)。首次封锁期间30天死亡率率比1.28(1.23–1.32),第二次封锁1.20(1.16–1.24),呼吸病、癌症、肺炎、脓毒症在封锁间期也持续升高。作者认为需加强对严重非新冠疾病的关注与管理。
要点
- 首次全国封锁后非新冠住院率由基线204.1/10万人周降至142.8/10万人周(率比0.70,95%CI 0.66–0.74)。
- 第二次全国封锁时非新冠住院率158.3/10万人周(率比0.78,95%CI 0.73–0.82),仍未回到基线。
- 首次封锁期间30天死亡率率比1.28(95%CI 1.23–1.32),第二次封锁1.20(1.16–1.24)。
- 非新冠呼吸病、神经系统病、癌症、心衰、脓毒症、非新冠呼吸道感染住院率在整个研究期间持续低于基线。
- 非新冠呼吸病、癌症、肺炎、脓毒症的30天死亡率在封锁间期也升高。
适用人群与场景
- 丹麦全部1岁以上居民(5,753,179人),观察567.8百万人周,纳入675,447人的1,113,705次住院。
- 比较疫情期(2020年3月11日至2021年1月27日)与疫情前基线(2019年3月13日至2020年3月10日)。
诊断标准与关键阈值
- 入院5天内被赋予新冠诊断代码的住院归类为新冠住院,其余为非新冠住院。
研究设计与关键结果
- nationwide population based cohort study:5,753,179名居民,567.8百万人周观察,1,113,705次住院(675,447人)。
- 非新冠住院率:基线204.1/10万人周;首次封锁后142.8/10万人周(率比0.70,95%CI 0.66–0.74);第二次封锁158.3/10万人周(率比0.78,95%CI 0.73–0.82)。
- 30天死亡率:首次封锁率比1.28(95%CI 1.23–1.32),第二次封锁率比1.20(95%CI 1.16–1.24),多数主要诊断组结果相似。
- 非新冠呼吸病、神经系统病、癌症、心衰、脓毒症、非新冠呼吸道感染住院率在整个研究期间持续低于基线。
- 非新冠呼吸病、癌症、肺炎、脓毒症的30天死亡率在封锁间期也升高。
证据类型、等级与局限
- 证据类型:全国人群队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需加强对严重非新冠疾病的管理与关注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the incidence of hospital admissions and associated mortality rates for non-covid medical conditions during the covid-19 pandemic.
DESIGN: Nationwide, population based cohort study.
SETTING: Denmark from 13 March 2019 to 27 January 2021.
PARTICIPANTS: All Danish residents >1 year of age.
MAIN OUTCOMES MEASURES: Population based healthcare registries that encompass the entire Danish population were used to compare hospital admission and mortality rates during the covid-19 pandemic (from 11 March 2020 to 27 January 2021) with the prepandemic baseline data (from 13 March 2019 to 10 March 2020). Hospital admissions were categorised as covid-19 when patients were assigned a diagnosis code for covid-19 within five days of admission. All patients were followed until migration, death, or end of follow-up, whichever came first. Rate ratios for hospital admissions were computed using Poisson regression and were directly standardised using the Danish population on 1 January 2019 as reference. 30 day mortality rate ratios were examined by Cox regression, adjusted for age and sex, and covid-19 diagnosis was used as a competing risk.
RESULTS: 5 753 179 residents were identified during 567.8 million person weeks of observation, with 1 113 705 hospital admissions among 675 447 people. Compared with the prepandemic baseline period (mean hospital admission rate 204.1 per 100 000/week), the overall hospital admission rate for non-covid-19 conditions decreased to 142.8 per 100 000/week (rate ratio 0.70, 95% confidence interval 0.66 to 0.74) after the first national lockdown, followed by a gradual return to baseline levels until the second national lockdown when it decreased to 158.3 per 100 000/week (0.78, 0.73 to 0.82). This pattern was mirrored for most major diagnosis groups except for non-covid-19 respiratory diseases, nervous system diseases, cancer, heart failure, sepsis, and non-covid-19 respiratory infections, which remained lower throughout the study period. Overall 30 day mortality rates were higher during the first national lockdown (mortality rate ratio 1.28, 95% confidence interval 1.23 to 1.32) and the second national lockdown (1.20, 1.16 to 1.24), and these results were similar across most major diagnosis groups. For non-covid-19 respiratory diseases, cancer, pneumonia, and sepsis, the 30 day mortality rate ratios were also higher between lockdown periods.
CONCLUSIONS: Hospital admissions for all major non-covid-19 disease groups decreased during national lockdowns compared with the prepandemic baseline period. Additionally, mortality rates were higher overall and for patients admitted to hospital with conditions such as respiratory diseases, cancer, pneumonia, and sepsis. Increased attention towards management of serious non-covid-19 medical conditions is warranted.
参考来源
- Bodilsen J, Nielsen PB, Søgaard M, et al. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study. BMJ. 2021. PMID: 34035000. doi:10.1136/bmj.n1135
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。